Physician profile
Daniel Van Galder
NPI 1437535325
$2,082.20
in general payments reported to CMS, 2019-2025
10 companies · $42.04 in 2025
The $42.04 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.00 · 2020: $325 · 2021: $1,006 · 2022: $363 · 2023: $148 · 2024: $147 · 2025: $42.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329 · Gift: $8.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.22 |
| Gift | $8.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,616.43 | 2020-2025 | |
| Biolase, INC. | $132.17 | 2020 | |
| Zest Holdings, LLC | $113.12 | 2024 | |
| Salvin Dental Specialties, INC. | $83.34 | 2020 | |
| Osteoready LLC | $50.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $25.55 | 2020 | |
| Zimvie INC. | $20.87 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $14.02 | 2022 | |
| Ultradent Products INC | $13.47 | 2024 | |
| Nobel Biocare USA | $13.23 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Van Galder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.